Home › Borstkanker › Connecticut › Bridgeport
Borstkanker klinische studies in Bridgeport, CT
21 studies voor Borstkanker zoeken deelnemers op locaties in en rond Bridgeport (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Stony Brook University Medical Center, Stony Brook · 18 mijl verwijderd
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
RekruterenFase 3
- Stony Brook University-Cancer Center ( Site 0034), Stony Brook · 18 mijl verwijderd
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RekruterenFase 3
- Research Site, Stony Brook · 18 mijl verwijderd
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
RekruterenFase 3
- Smilow Cancer Hospital Care Center - Trumbull, Trumbull · 4 mijl verwijderd
- Smilow Cancer Hospital Care Center - Fairfield, Fairfield · 5 mijl verwijderd
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Rekruteren
- Stony Brook Cancer Center, Stony Brook · 18 mijl verwijderd
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
RekruterenFase 1/2
- Stony Brook University Hospital, Stony Brook · 18 mijl verwijderd
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruterenFase 3
- Stony Brook University Medical Center, Stony Brook · 18 mijl verwijderd
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- Stony Brook University Cancer Center, Stony Brook · 18 mijl verwijderd
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruterenFase 3
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C. (Port Jefferson Station2), Port Jefferson Station · 19 mijl verwijderd
- New York Cancer and Blood Specialists_North Shore Hematology Oncology Assocaites P.C.(Port Jefferson Station1), Port Jefferson Station · 19 mijl verwijderd
- New York Cancers & Blood Specialists, Port Jefferson Station · 19 mijl verwijderd
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- Hartford HealthCare - Saint Vincent's Medical Center, Bridgeport
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mijl verwijderd
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mijl verwijderd
- en nog 1
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
RekruterenFase 2
- Stony Brook Cancer Center, Stony Brook · 18 mijl verwijderd
ATEMPT 2.0: Adjuvant T-DM1 vs TH
RekruterenFase 2
- Smilow Cancer Hospital Care center at Trumbull, Trumbull · 4 mijl verwijderd
- Smilow Cancer Hospital Care center at Fairfield, Fairfield · 5 mijl verwijderd
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
RekruterenFase 1
- New York Cancer and Blood Specialists, Port Jefferson Station · 19 mijl verwijderd
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruterenFase 3
- Stony Brook University Cancer Center, Stony Brook · 18 mijl verwijderd
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RekruterenFase 3
- Smilow Cancer Hospital - Fairfield, Fairfield · 5 mijl verwijderd
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
RekruterenFase 3
- Smilow Cancer Hospital Care Center-Trumbull, Trumbull · 4 mijl verwijderd
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield · 5 mijl verwijderd
- Stony Brook University Medical Center, Stony Brook · 18 mijl verwijderd
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
RekruterenObservatieonderzoek
- Stony Brook Medicine, Stony Brook · 18 mijl verwijderd
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast Cancer
RekruterenVroege fase 1
- Stony Brook Breast Center, Stony Brook · 18 mijl verwijderd
Definitive Radiation Therapy for Inoperable Breast Cancer
Rekruteren
- Stony Brook University Cancer Center, Stony Brook · 18 mijl verwijderd
Definitive Radiation for High-Risk Spine Metastases
RekruterenFase 2
- Stony Brook University Hospital, Stony Brook · 18 mijl verwijderd
CtDNA Based MRD Testing for NAC Monitoring in TNBC
RekruterenObservatieonderzoek
- Stony Brook University Cancer Center, Stony Brook · 18 mijl verwijderd
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in Bridgeport
- Niet-kleincellige longkanker14 studies
- Longkanker13 studies
- Acute myeloïde leukemie12 studies
- Cardiovasculaire ziekte9 studies
- Kanker (alle vormen)8 studies
- Plaveiselcelcarcinoom van hoofd en hals8 studies
- Metastatische kanker7 studies
- Hartfalen7 studies
- Hersenaneurysma6 studies
- Multipel myeloom6 studies
- Prostaatkanker6 studies
- Eierstokkanker5 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.